. Author manuscript; available in PMC: 2010 Nov 1.

Published in final edited form as: J Antibiot (Tokyo). 2010 Mar 26;63(5):219–224. doi: 10.1038/ja.2010.22

Table 2.

Antibacterial activity of Etamycin

Strain	MIC (mg/L)
HA- and CA-MRSA Strains
UAMS-1 (USA200)	1 – 2
Sanger 252	8 – 16 (2)^*
ATCC 33591	16
NRS22 (USA600)	1 – 4
NRS119 (linezolid-resistant strain)	1 – 2
UAMS-1182 (USA300)	4
NRS192	2
NRS386 (USA700)^**	2
Non-MRSA Strains
E. faecalis (vanB)	16 (16)
S. pyogenes (M1 strain 5448)	8
S. agalactiae (serotype III strain COH1)	8
M. catarrhalis (ATCC 25238)	1
H. influenzae (type b, ATCC 10211)	16
E. coli (ATCC 25922)	>256
S. typhimurium (ATCC 13311)	>256
P. aeruginosa (ATCC 27853)	>256

Values in parentheses represent MICs for Synercid against these bacterial strains tested under identical conditions as for etamycin.

^**

Strain NRS386 is associated with both community and healthcare infections.